Market Introduction
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
Market Overview and Dynamics
The North America cell line development market is expected to reach US$ 3,849.54million in 2027 from US$ 1,401.23million in 2019. The market is estimated to grow with a CAGR of 13.6% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the high rise in the number of cancer cases across North America and the increasing development in the biotechnology sector. However, the market growth is likely to be hindered owing to the cell line contamination by various microorganisms.
Key Market Segments
Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, and media & reagent. Based on application, the cell line development market, is segmented into drug discovery, bioproduction, and tissue engineering.
Major Sources and Companies Listed
Some of the major primary and secondary sources for cell line development market included in the report are California Institute for Regenerative Medicine (CIRM), the American Society of Clinical Oncology, A Cancer Journal for Clinicians, and others.
Reasons to buy the report
- To understand the North America cell line development market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for cell line development market
- Efficiently plan M&A and partnership deals in North America cell line development market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form cell line development market
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region
NORTH AMERICA CELL LINE DEVELOPMENT MARKET SEGMENTATION
By Type
- Primary Cell Line
- Hybridomas
- Continuous Cell Lines
- Recombinant Cell Line
- Equipment
- Media & Reagent
By Country
- North America
- US
- Canada
- Mexico
Company Profiles
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- SELEXIS
- BioFactura, Inc.
- WuXi AppTec
- LakePharma, Inc.
- General Electric
- Lonza
- Corning Incorporated
North America Cell Line Development Market Strategic Insights
North America Cell Line Development Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 1,401.23 Million |
| Market Size by 2027 | US$ 3,849.54 Million |
| CAGR (2020 - 2027) | 13.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Cell Line Development Market Country and Regional Insights
